Citations

Showing 10 of 108152 citations.

Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health
Pavlovska, Iuliia , Polcrová, Anna Bartošková , Brož, Jan , Infante-García, María M., Neto, Geraldo de Albuquerque Maranhão , Kunzová, Šárka , Skladaná, Mária , Novotný, Jan , Pikhart, Hynek , Urbanová, Jana , Medina‐Inojosa, José R. , Vysoký, Robert , González‐Rivas, Juan P. , Brož, Jan , Kunzova, Sarka , Skladana, Maria , Novotny, Jan S , Urbanová, Jana , Medina-Inojosa, José R , González-Rivas, Juan P , Maranhao Neto, Geraldo A , Polcrova, Anna , Mechanick, Jeffrey I. , Nieto‐Martínez, Ramfis , Stokin, Gorazd B.

Mayo Clinic

Nutrients | July 8, 2021 | Volume: 13 | Issue: 7 | Pages: 2338

10.3390/nu13072338 | PMID 34371848 Get It

In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.
Extended Anterior Inferior Approach to Endoscopic Medial Maxillectomy for Maxillary Sinus Lesions
Huang, Alice E. , Low, Christopher M. , Stokken, Janalee K., Stokken, Janalee K. , Carlson, Matthew L

Mayo Clinic

American Journal of Rhinology & Allergy | July 8, 2021 | Volume: 35 | Issue: 6 | Pages: 895-901

10.1177/19458924211025371 | PMID 34236250 Get It

Background Myriad open and endoscopic approaches are employed to resect maxillary sinus lesions, each with associated advantages and disadvantages. The inferior and anterior portion of the sinus remains a challenging space to access. Objectives To describe the extended anterior inferior approach to endoscopic medial maxillectomy (EAMM) as a novel and valuable addition to a stepwise approach for minimizing surgical morbidity without compromising tumor outcomes. To report the outcomes of patients treated with this approach. Methods A retrospective case series study of 9 patients who underwent EAMM between 2016 and 2019 at a tertiary care referral center was performed. The endoscopic technique is described. The duration of follow-up ranged from 1 to 53 months. Intraoperative steps, including transection of the nasolacrimal duct and execution of an intraoperative dacryocystorhinostomy, were reviewed. Postoperative outcomes, including patient symptoms at follow-up and tumor recurrence, were recorded. Results Adequate exposure with gross total tumor resection or margin-negative tumor resection was achieved in all cases. Sparing of the nasolacrimal duct was achieved in 2 patients. No patients reported persistent epiphora, empty nose syndrome, or changes in cosmesis such as alar or nasal tip collapse. One patient reported unilateral V2 hypoesthesia at 6 months postoperatively that had resolved by his next follow-up 18 months after surgery. Postoperative tumor surveillance was achieved by endoscopic examinations in all patients and there was no evidence of tumor recurrence at a median follow-up of 22 months. Conclusions The EAMM provides improved access to the inferior–posterior–medial maxillary sinus. This approach minimizes the risk of hypoesthesia and change in cosmesis present in other approaches, and obviates division of the nasolacrimal duct for inferior, posterior–medial attached lesions. This progressive escalation of approach for maxillary sinus lesions minimizes injury to nasal and nasolacrimal structures without compromising tumor outcomes.
Pain Experience in Pancreatitis: Strong Association of Genetic Risk Loci for Anxiety and PTSD in Patients With Severe, Constant, and Constant-Severe Pain
Dunbar, Ellyn, Greer, Phil J. , Alkaade, Samer, Banks, Peter A. , Conwell, Darwin L. , Forsmark, Christopher E., Gardner, Timothy B. , Guda, Nalini M. , Machicado, Jorge D. , Muniraj, Thiruvengadam , Romagnuolo, Joseph , Sandhu, Bimaljit S., Sherman, Stuart , Slivka, Adam, Wilcox, C. Mel , Yadav, Dhiraj , Whitcomb, David C. , Lewis, Michele D. , Whitcomb, David C , Amann, Stephen T. , Brand, Randall E. , Papachristou, Georgios I.

Mayo Clinic

American Journal of Gastroenterology | July 8, 2021 | Volume: 116 | Issue: 10 | Pages: 2128-2136

10.14309/ajg.0000000000001366 | PMID 34236339 Get It

INTRODUCTION: Recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP) are progressive inflammatory syndromes with variable features. Pain is the primary feature that contributes to low physical and mental quality of life with a third of patients reporting severe pain. Pain experience is worsened by depression. Here, we tested the hypothesis that genetic risk of the psychiatric conditions of anxiety and post-traumatic stress disorder (PTSD) is associated with pain in CP and RAP + CP subjects. METHODS: The study cohort included phenotyped and genotyped RAP and CP patients from the North American Pancreatitis Study II of European Ancestry. Candidate genetic association studies were based on the absence of pain vs pain that is constant, constant-severe, or severe. Twenty-eight candidate genetic loci for anxiety and PTSD risk were identified in the literature and were the focus of this study. RESULTS: We identified 24 significant pain-associated single nucleotide polymorphisms within 13 loci across the 3 pain patterns in CP and RAP + CP ( P < 0.002). Thirteen anxiety or PTSD genes were within these pain loci indicating nonrandom associations ( P < 4.885 × 10 −23 ). CTNND2 was associated with all pain categories and all pancreatitis etiologies. Implicated systems include neuronal signaling ( HTR2A , DRD3 , NPY , and BDNF ), hypothalamic-pituitary-adrenal axis ( NR3C1 and FKBP5 ), and cell-cell interaction ( CTNND2 and THBS2 ). DISCUSSION: A component of constant and severe pain in patients with RAP and CP is associated with genetic predisposition to anxiety and PTSD. Identification of patients at risk eligible for trials of targeted treatment as a component of a multidisciplinary pain management strategy should be formally evaluated.
Treatment of hypothyroidism in the Middle East
Gharib, Hossein

Mayo Clinic

Journal of Diabetes and Endocrine Practice | July 8, 2021 | Volume: 04 | Issue: 02 | Pages: 44-45

10.4103/jdep.jdep_20_21 Get It

Red blood cell frequencies and genetic polymorphisms of various blood grouping systems in the emirati population
Alhumaidan, Hiba, Omeziane, Naima, Alvares, Marion , Yafei, Zain Al, Mahri, Ayeda Al, ElGhazali, Gehad , Zaabi, Eiman Al , Edinur, Hisham Atan

Mayo Clinic

ISBT Science Series | July 8, 2021 | Volume: 16 | Issue: 4 | Pages: 293-306

10.1111/voxs.12643 Get It

AbstractBackground and objectivesData on the frequencies of RBC antigens and their variants in the Arab world are limited. Thus, determining the antigenic profile of the United Arab Emirates (UAE) population by serologic and molecular methods is significant to enhance operational efficiency in donor centres and transfusion services.Study design and methodsThe study is a retrospective retrieval of serologic and genotype data. The serological ABO type data of 30 954 UAE national donors, the serological RHD and RHCE data of 10 036 UAE national donors, and the genotype data of 354 patients and donors of admixed nationalities for determining different blood group systems were retrieved and analysed.ResultsRh D negative (dccee) phenotype in the UAE national donor population is lower compared to the reported Rh D negative phenotype in the European population (6·8% vs. 18%) and there were a high number of variants observed in the patient and donor populations, especially in the RhCE and Duffy blood group systems (12·1% and 59·3%, respectively).ConclusionHigh number of variants and rare blood group profiles were observed and the gene pool of the Emirati nationals, as well as their antigenic frequencies, is an intermediate between the European and African populations rather than the Asian gene pool.
Central Sensitization Symptom Severity and Patient-Provider Relationships in a Community Setting
Ebbert, Jon O. , Gilman, Elizabeth A. , Rosedahl, Jordan K., Ramar, Priya , Philpot, Lindsey M. , Philpot, Lindsey M , Wang, Xiao‐Jing

Mayo Clinic

Journal of Primary Care & Community Health | July 8, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211031767 | PMID 34235997 Get It

Introduction Central sensitization syndromes (CSS) comprise an overlapping group of clinical conditions with the core feature of “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system.” Patients with CSS are known to have challenging interactions with healthcare providers contributing to psychological distress and increased healthcare utilization. CSS symptom severity has been associated with psychologic comorbidities, but little is known about how symptom severity relates to provider interactions. Methods We performed a cross-sectional survey among patients with CSS in our primary care practices to examine the relationship between CSS symptom severity and experiences with doctors. Results A total of 775 respondents completed the survey (775/5000; 15.5%) with 72% reporting high CSS symptom severity. About 44% of respondents had a prior diagnosis of fibromyalgia, 72% had migraines, and 28% had IBS. Patients with high CSS symptom severity were more likely to report that doctor(s) had often/always told them that they don’t need treatment when they feel like they do (OR = 3.6, 95% CI 1.9-7.5), that doctor(s) often/always don’t understand them (OR = 3.1, 95% CI 1.9-5.4), and that doctor(s) often/always seem annoyed with them when compared with respondents with low-moderate CSS symptom severity (OR = 4.8, 95% CI 2.2-12.5). Patients with high CSS symptom severity were at greater than 5 times odds of reporting being told that their symptoms were “all in their head” when compared to patients with low-moderate symptom severity (OR = 5.4, 95% CI 3.3-9.0). Conclusion Patients with CSS spectrum disorders experience frequent pain and decreased quality of life. A high degree of CSS symptom severity is associated with negative experiences with healthcare providers, which deters the establishment of a positive provider-patient relationship. Further research is needed to help understand symptom severity in CSS and harness the power of the therapeutic alliance as a treatment modality.
Subarachnoid hemorrhage from sudden gravitational changes
Braksick, Sherri A. , Braksick, Sherri A , Rabinstein, Alejandro A. , Wijdicks, Eelco F. M.

Mayo Clinic

The Neuroradiology Journal | July 8, 2021 | Volume: 35 | Issue: 2 | Pages: 240-242

10.1177/19714009211030540 | PMID 34235989 Get It

Diffuse subarachnoid hemorrhage is commonly attributed to the rupture of intracranial aneurysms or other vascular malformations. Non-aneurysmal hemorrhages often have a characteristic pattern or clear mechanism (e.g. trauma) with an often more benign clinical course. We report the case of a diffuse non-aneurysmal subarachnoid hemorrhage due to sudden gravitational changes encountered during complex airflight maneuvers, complicated by hydrocephalus and cerebral vasospasm. This case illustrates a rare phenomenon that may again be encountered in the future with the advent and advancement of civilian spaceflight.
Is There a Difference in Screw Accuracy, Robot Time Per Screw, Robot Abandonment, and Radiation Exposure Between the Mazor X and the Renaissance? A Propensity-Matched Analysis of 1179 Robot-Assisted Screws
Lee, Nathan J. , Buchanan, Ian A. , Boddapati, Venkat , Mathew, Justin , Robertson, Djani, Lakomkin, Nikita , Park, Paul , Leung, Eric , Lombardi, Joseph M. , Lehman, Ronald A. , Mathew, Justin , Leung, Eric , Zuckerman, Scott L. , Marciano, Gerard F.

Mayo Clinic

Global Spine Journal | July 8, 2021 | Volume: 13 | Issue: 5 | Pages: 1286-1292

10.1177/21925682211029867 | PMID 34235996 Get It

Study Design: Prospective single-cohort analysis. Objectives: To compare the outcomes/complications of 2 robotic systems for spine surgery. Methods: Adult patients (≥18-years-old) who underwent robot-assisted spine surgery from 2016-2019 were assessed. A propensity score matching (PSM) algorithm was used to match Mazor X to Renaissance cases. Preoperative CT scan for planning and an intraoperative O-arm for screw evaluation were preformed. Outcomes included screw accuracy, robot time/screw, robot abandonment, and radiation. Screw accuracy was measured using Vitrea Core software by 2 orthopedic surgeons. Screw breach was measured according to the Gertzbein/Robbins classification. Results: After PSA, a total of 65 patients (Renaissance: 22 vs. X: 43) were included. Patient/operative factors were similar between robot systems ( P > .05). The pedicle screw accuracy was similar between robots (Renaissance: 1.1%% vs. X: 1.3%, P = .786); however, the S2AI screw breach rate was significantly lower for the X (Renaissance: 9.5% vs. X: 1.2%, P = .025). Robot time per screw was not statistically different (Renaissance: 4.6 minutes vs. X: 3.9 minutes, P = .246). The X was more reliable with an abandonment rate of 2.3% vs. Renaissance:22.7%, P = .007. Radiation exposure were not different between robot systems. Non-robot related complications including dural tear, loss of motor/sensory function, and blood transfusion were similar between robot systems. Conclusion: This is the first comparative analyses of screw accuracy, robot time/screw, robot abandonment, and radiation exposure between the Mazor X and Renaissance systems. There are substantial improvements in the X robot, particularly in the perioperative planning processes, which likely contribute to the X’s superiority in S2AI screw accuracy by nearly 8-fold and robot reliability by nearly 10-fold.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa
Gorelik, Mark , Langford, Carol A. , Maz, Mehrdad , Abril, Andy , Archer, Amy M., Conn, Doyt L. , Full, Kathy A., Grayson, Peter C. , Ibarra, Maria, Imundo, Lisa F., Kim, Susan , Rhee, Rennie L. , Stone, John H. , Sule, Sangeeta , Vitobaldi, Omar I., Warner, Ann, Byram, Kevin , Dua, Anisha B. , Husainat, Nedaa , James, Karen , Kalot, Mohamad A. , Lin, Yih Chang, Springer, Jason , Turgunbaev, Marat, Villa‐Forte, Alexandra, Turner, Amy S. , Maz, Mehrdad , Conn, Doyt L , Grayson, Peter C , Merkel, Peter A , Rhee, Rennie L , Stone, John H , Sule, Sangeeta , Husainat, Nedaa M , Kalot, Mohamad A , Springer, Jason M , Turner, Amy S , Mustafa, Reem A , Dua, Anisha B , Chung, Sharon A. , Guyatt, Gordon , Merkel, Peter A. , Seo, Philip , Sundel, Robert P. , Warner, Ann

Mayo Clinic

Arthritis Care & Research | July 8, 2021 | Volume: 73 | Issue: 8 | Pages: 1061-1070

10.1002/acr.24633 | PMID 34235889 Get It

Objective To provide evidence‐based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Methods Twenty‐one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic, non–hepatitis B–related PAN. Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel. Results We present 16 recommendations and 1 ungraded position statement for PAN. Most recommendations were graded as conditional due to the paucity of evidence. These recommendations support early treatment of severe PAN with cyclophosphamide and glucocorticoids, limiting toxicity through minimizing long‐term exposure to both treatments, and the use of imaging and tissue biopsy for disease diagnosis. These recommendations endorse minimizing risk to the patient by using established therapy at disease onset and identify new areas where adjunctive therapy may be warranted. Conclusion These recommendations provide guidance regarding diagnostic strategies, use of pharmacologic agents, and imaging for patients with PAN.
Nasal Septal Perforation Due to Desmopressin Nasal Spray Use
Brake, Daniela A. , Bansberg, Stephen F. , Hamilton, Grant

Mayo Clinic

Ear, Nose & Throat Journal | July 8, 2021 | Volume: 102 | Issue: 12 | Pages: NP621-NP624

10.1177/01455613211026425 | PMID 34233494 Get It

Perforations of the nasal septum have many etiologies and occasionally result from intranasal medicated spray use. This case report describes a perforation related to the use of desmopressin nasal spray, which has not been previously reported in the literature. Clinical considerations presented in this article include appropriate technique of nasal spray application, appropriate monitoring of patients on intranasal sprays, and indications for evaluation by an otolaryngologist. Septal perforation treatment success is improved with an early diagnosis.